← back to search

Qi Jiang

Inner Mongolia University · CN
Area of research
Statistics and Probability · Hematology
Research interest
Research interests include Statistical Methods in Clinical Trials, Gastrointestinal Tumor Research and Treatment, Acute Myeloid Leukemia Research, and Health Systems, Economic Evaluations, Quality of Life.
h-index
35
citations
9,408
works
167
NIH funding
primary concept
Medicine
email

Recent publications

Distinguishing very high-risk patients among high-risk gastrointestinal stromal tumor cases: development and validation of a nomogram based on a multicenter population-based retrospective cohort study
Annals of Medicine 2025cited by 1position: firstdoi
USP29 and SMURF1 orchestrate FSP1-mediated ferroptosis suppression to facilitate chemoresistance in gastric cancer.
2025cited by 0position: contributordoi
Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis
Blood 2023cited by 37position: middledoi
Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two‐sample Mendelian randomization analysis of European and East Asian populations
Cancer Medicine 2023cited by 28position: middledoi
Targeting BCL6 in Gastrointestinal Stromal Tumor Promotes p53-Mediated Apoptosis to Enhance the Antitumor Activity of Imatinib.
2023cited by 12position: contributordoi
Use of Nonconcurrent Common Control in Master Protocols in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion
Statistics in Biopharmaceutical Research 2021cited by 35position: middledoi
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
Blood 2020cited by 747position: middledoi
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow‐up from a phase 1b study
American Journal of Hematology 2020cited by 164position: middledoi
Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer
Gut 2019cited by 440position: middledoi
Outcomes after Stem Cell Transplant in Older Patients with Acute Myeloid Leukemia Treated with Venetoclax-Based Therapies
Blood 2019cited by 27position: middledoi
Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion
European Urology 2018cited by 205position: middledoi
CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer
Cancer Immunology Immunotherapy 2018cited by 51position: firstdoi
Predictive value of F-18 FDG PET/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants
Medical Oncology 2014cited by 67position: middledoi
Comparison Between Decitabine and Azacitidine for the Treatment of Myelodysplastic Syndrome: A Meta-Analysis With 1392 Participants
Clinical Lymphoma Myeloma & Leukemia 2014cited by 46position: middledoi
Pain outcomes in patients with advanced breast cancer and bone metastases
Cancer 2012cited by 155position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jiejie Xu · Shanghai Medical College of Fudan University3 papers (2018–2019)Jalaja Potluri · AbbVie (United States)3 papers (2019–2023)Courtney D. DiNardo · The University of Texas MD Anderson Cancer Center3 papers (2019–2020)Weijuan Zhang · Fudan University3 papers (2018–2019)Keith W. Pratz · Abramson Cancer Center2 papers (2019–2020)Pamela S. Becker · City Of Hope National Medical Center2 papers (2019–2020)Brenda Chyla · AbbVie (United States)2 papers (2020–2020)Kaixiong Tao · Second People's Hospital of Yunnan Province2 papers (2023–2025)Junyu Zhang · Fudan University2 papers (2018–2018)Yu Zhu · Fudan University2 papers (2018–2018)Zhenkun Lou · Mayo Clinic in Arizona2 papers (2023–2025)Mixue Xie · Fudan University2 papers (2014–2014)John Hayslip · Verastem (United States)2 papers (2019–2020)Le Xu · Shandong University of Technology2 papers (2018–2018) · 2 papers (2023–2025) · 2 papers (2023–2025) · 2 papers (2023–2025) · 2 papers (2023–2025)Andrew H. Wei · CSL (Australia)2 papers (2020–2020)Martha Arellano · Emory University2 papers (2019–2020)